SYK and retinoblastoma: A pro-survival role for Syk is also seen in retinoblastoma where the addition of the Syk inhibitor BAY61-3606 to the chemotherapeutic regimen used to treat retinoblastoma in a mouse model significantly improves outcomes [17].